Drug Database
N04BC05 pramipexole
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Glepark 0.088mg, 0.18mg, 0.35mg, 0.7mg Tablets
- POM MIRAPEXIN 0.088 mg/0.18 mg/0.35 mg/0.7 mg tablets
- POM MIRAPEXIN prolonged-release tablets
- POM Pipexus prolonged-release tablets
- POM Pramipexole 0.088 mg tablets
- POM Pramipexole 0.088 mg tablets
- POM Pramipexole 0.088mg Tablets
- POM Pramipexole 0.18 mg tablets
- POM Pramipexole 0.18 mg tablets
- POM Pramipexole 0.18mg Tablets
- POM Pramipexole 0.35 mg tablets
- POM Pramipexole 0.35 mg tablets
- POM Pramipexole 0.7 mg tablets
- POM Pramipexole 0.7 mg tablets
- POM Pramipexole 0.7mg Tablets
- POM Pramipexole 1.1 mg tablets
- POM Pramipexole Krka 0.26 mg prolonged-release tablets
- POM Pramipexole Krka 0.52 mg prolonged-release tablets
- POM Pramipexole Krka 1.05 mg prolonged-release tablets
- POM Pramipexole Krka 1.57 mg prolonged-release tablets
- POM Pramipexole Krka 2.1 mg prolonged-release tablets
- POM Pramipexole Krka 2.62 mg prolonged-release tablets
- POM Pramipexole Krka 3.15 mg prolonged-release tablets
- POM Pramipexole Mylan 0.088 mg tablets
- POM Pramipexole Mylan 0.18 mg tablets
- POM Pramipexole Mylan 0.26 mg Prolonged-release Tablets
- POM Pramipexole Mylan 0.35 mg tablets
- POM Pramipexole Mylan 0.52 mg Prolonged-release Tablets
- POM Pramipexole Mylan 1.05 mg Prolonged-release Tablets
- POM Pramipexole Mylan 1.57 mg Prolonged-release Tablets
- POM Pramipexole Mylan 2.1 mg Prolonged-release Tablets
- POM Pramipexole Mylan 2.62 mg Prolonged-release Tablets
- POM Pramipexole Mylan 3.15 mg Prolonged-release Tablets
- POM Pramipexole Zentiva 0.26 mg prolonged-release tablets
- POM Pramipexole Zentiva 0.52 mg prolonged-release tablets
- POM Pramipexole Zentiva 1.05 mg prolonged-release tablets
- POM Pramipexole Zentiva 1.57 mg prolonged-release tablets
- POM Pramipexole Zentiva 2.10 mg prolonged-release tablets
- POM Pramipexole Zentiva 2.62 mg prolonged-release tablets
- POM Pramipexole Zentiva 3.15 mg prolonged-release tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).